Walgreens Boots Alliance Class Action Lawsuit
Analysis based on 9 articles · First reported Feb 01, 2025 · Last updated Feb 15, 2025
The class action lawsuit against Walgreens Boots Alliance, following a civil complaint from the United States — United States Department of Justice, has led to a significant drop in Walgreens Boots Alliance's stock price. This event highlights the financial risks associated with regulatory non-compliance in the healthcare and pharmacy sectors, potentially impacting investor confidence in similar companies.
Walgreens Boots Alliance is facing a class action lawsuit led by Robbins Geller Rudman & Dowd LLP, on behalf of investors who purchased its common stock between April 2, 2020, and January 16, 2025. The lawsuit alleges that Walgreens Boots Alliance made false and misleading statements and failed to disclose widespread violations of federal law regarding prescription medication dispensation and reimbursement. This legal action follows a civil complaint filed by the United States — United States Department of Justice on January 17, 2025, accusing Walgreens Boots Alliance of dispensing millions of unlawful prescriptions in violation of the Controlled Substances Act and seeking reimbursement through the False Claims Act. Upon this news, Walgreens Boots Alliance's stock price fell over 12% in two trading sessions.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard